Tag: BASIL-2

BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients

A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...

BASIL-2 points towards endovascular-first revascularisation strategy in CLTI patients

A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to...
BASIL-2

CX 2023 highlight: The BASIL-2 trial

Data and discussion on revascularisation treatment strategies for patients with chronic limb-threatening ischaemia (CLTI) will take centre stage at the CX 2023 Consensus update,...

Vascular News 97 – February 2023 US Edition

In this issue: CX 2023 preview: Headline peripheral session to spotlight audience view on new BASIL-2 findings Journal highlight: Individual patient data meta-analysis probes safety...